Neuronetics, Inc.
STIM
$2.74
-$0.13-4.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 38.11M | 31.98M | 22.49M | 18.53M | 16.45M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 38.11M | 31.98M | 22.49M | 18.53M | 16.45M |
| Cost of Revenue | 20.35M | 16.24M | 7.00M | 4.53M | 4.27M |
| Gross Profit | 17.76M | 15.74M | 15.49M | 14.00M | 12.18M |
| SG&A Expenses | 24.02M | 25.14M | 20.59M | 19.31M | 18.45M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 46.17M | 42.99M | 33.37M | 26.26M | 24.96M |
| Operating Income | -8.06M | -11.01M | -10.87M | -7.73M | -8.51M |
| Income Before Tax | -9.84M | -12.69M | -12.68M | -13.34M | -9.83M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.84M | -12.69M | -12.68M | -13.34M | -9.83M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -281.00K | 14.00K | 19.00K | -- | -- |
| Net Income | -10.12M | -12.68M | -12.66M | -13.34M | -9.83M |
| EBIT | -8.06M | -11.01M | -10.87M | -7.73M | -8.51M |
| EBITDA | -7.26M | -10.10M | -10.52M | -7.17M | -8.05M |
| EPS Basic | -0.15 | -0.21 | -0.35 | -0.44 | -0.33 |
| Normalized Basic EPS | -0.10 | -0.13 | -0.25 | -0.18 | -0.20 |
| EPS Diluted | -0.15 | -0.21 | -0.35 | -0.44 | -0.33 |
| Normalized Diluted EPS | -0.10 | -0.13 | -0.25 | -0.18 | -0.20 |
| Average Basic Shares Outstanding | 66.18M | 61.47M | 36.67M | 30.27M | 30.05M |
| Average Diluted Shares Outstanding | 66.18M | 61.47M | 36.67M | 30.27M | 30.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |